Viewing nowMontelukast Sodium 10 mg
Montelukast Sodium 10.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

MFDS item code 200810868 · Approved 2008.11.07
Prevention and long-term treatment of asthma; relief of symptoms of allergic rhinitis
This medication is used to prevent and continuously treat asthma. It also helps alleviate symptoms of seasonal and perennial allergic rhinitis. Both conditions are important for improving respiratory health and reducing symptoms. Therefore, it is effectively used for patients with asthma and allergic rhinitis.
Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the dosing time should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening. Asthma or allergic rhinitis 10 mg tablets Adults and adolescents aged 15 years and older: Administer 10 mg of montelukast orally once daily.
This medication should not be administered to patients with a hereditary condition known as phenylketonuria, as the artificial sweetener aspartame included in this medication is broken down into phenylalanine in the body. The daily intake of aspartame should be limited to below the WHO recommended amount of 40 mg/kg, with a maximum of 2.4 g per day for adults. Patients with allergic reactions to this medication or hypersensitivity to its components should not take it. This medication also contains lactose and should not be taken by patients with genetic conditions such as lactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. This medication is not intended for use during acute asthma attacks, and patients should always carry appropriate emergency medications if asthma worsens. When reducing the dose of inhaled corticosteroids, it should be done gradually under medical supervision, and patients should not abruptly switch to other medications. Patients taking this medication may experience neuropsychiatric symptoms, so the patient or caregiver should immediately inform a doctor if such symptoms occur. Patients with exercise-induced bronchospasm should not use this medication alone and should continue using inhaled β-agonists, keeping a rapid-acting inhaler ready in case of emergencies. Patients with aspirin hypersensitivity should not take aspirin or nonsteroidal anti-inflammatory drugs while on this medication. Patients taking this medication may experience rare symptoms of vasculitis associated with eosinophilia, so doctors should carefully monitor for worsening pulmonary symptoms or skin rashes. Co-administration with other asthma treatments has not generally reported significant drug interactions; however, clinical monitoring may be needed when used with certain drugs. Pregnant women must consult a doctor before taking this medication, and caution is also needed for breastfeeding women. This medication can also be used in children and the elderly, but safety and efficacy may vary according to age, so it should be taken under the guidance of a professional. In case of overdose, there is no specific antidote, so the patient should receive general symptomatic treatment under the guidance of a doctor. This medication is sensitive to light, so it should be taken immediately after opening the package, and kept out of reach of children. Finally, this medication should be taken consistently even if asthma symptoms are not present, and if symptoms worsen, a doctor should be consulted immediately.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air, moisture, and light, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1°C and 30°C to effectively preserve the medication's efficacy.
Light apricot-colored, rounded square-shaped film-coated tablet
28 tablets (7 tablets/PTP x 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 10.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.